Cargando…

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA

Detalles Bibliográficos
Autores principales:	Booth, Clare L, McCormick, Adele, Garcia-Diaz, Ana, Macartney, Malcolm, Youle, Michael, Johnson, Margaret, Webster, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072201/ http://dx.doi.org/10.1186/1471-2334-14-S4-O25

Ejemplares similares

Epigenetic modifications of HIV proviral LTRs: potential targets for cure
por: Doerfler, W, et al.
Publicado: (2012)

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient
por: Trabaud, MA, et al.
Publicado: (2014)

Epigenetic drug Gar1041 in combination with antiretroviral therapy transiently reduces the proviral DNA reservoir in SIVmac251-infected macaques
por: Lewis, MG, et al.
Publicado: (2010)

Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek(®)-HIV system
por: Garcia-Diaz, Ana, et al.
Publicado: (2014)

The frequencies of naturally occurring protease inhibitor resistance mutations in HIV proviral sequences of drug naïve sex workers in Nairobi, Kenya and their correlation with host immune response driven positively selected mutations in HIV-1
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

Telomere length, proviral load and neurologic impairment in HTLV-1-and HTLV-2-infected humans
por: Usadi, Benjamin, et al.
Publicado: (2014)

Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients
por: Sousa, Alessandra de Paula A, et al.
Publicado: (2015)

Co-receptor usage prediction at quasispecies level using ultra-deep pyrosequencing on both circulating and proviral hiv in patients candidates to CCR5 antagonist treatment
por: Abbate, Isabella, et al.
Publicado: (2010)

Massive depletion of BLV proviral clones located in genomic transcriptionally active sites during primary infection
por: Gillet, Nicolas A, et al.
Publicado: (2014)

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus
por: Dragovic, Gordana, et al.
Publicado: (2014)

Mother to child transmission (MTCT) of HIV - almost a thing of the past? A cohort study of HIV positive women starting antiretroviral drugs in pregnancy
por: Leonard, Hugh A, et al.
Publicado: (2014)

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study
por: Garcia, Federico, et al.
Publicado: (2014)

Comparative demographics of the European Cystic Fibrosis population: does EU membership confer an advantage?
por: Mehta, Anil, et al.
Publicado: (2010)

The international mobility of UK students; a government funded initiative
por: McCormick, Keith, et al.
Publicado: (2010)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011)

Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV-positive patients on HAART
por: Mexas, A, et al.
Publicado: (2010)

Is a cure for HIV feasible? A proof-of-concept in humanized mice
por: Speck, Roberto
Publicado: (2013)

Barriers to blinding: an analysis of the feasibility of blinding in test-treatment RCTS
por: di Ruffano, Lavinia Ferrante, et al.
Publicado: (2015)

Damaging the Integrated HIV Proviral DNA with TALENs
por: Strong, Christy L., et al.
Publicado: (2015)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Differential modulation of human beta-defensin-3 expression in human oral epithelial cells by HPV oncoproteins E6 and E7: potential implication in oral cancer
por: Jin, Ge, et al.
Publicado: (2012)

Testing alertness of Helicopter Emergency Medical Service (HEMS) crews – a feasibility study
por: Cullip, Teresa, et al.
Publicado: (2014)

Gene looping between the viral LTRs is a hallmark of transcriptionally active HIV-1 and Mo-MLV proviral DNA
por: Vardabasso, Chiara, et al.
Publicado: (2009)

HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
por: Joachim, A, et al.
Publicado: (2012)

Transportin HIV-1 by tRNAin and CAr
por: Zhou, Lihong, et al.
Publicado: (2011)

Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing
por: Vandekerckhove, LPR, et al.
Publicado: (2010)

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Value of saliva testing when added to questionnaire screening for unhealthy drug use
por: Saade, H John, et al.
Publicado: (2015)

Correction: HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Can we implement findings from RCTs of diagnostic tests? A review of reporting of test-treat interventions
por: di Ruffano, Lavinia Ferrante, et al.
Publicado: (2015)

The changing face of HIV resistance; HIV drug resistance north and south — what's next?
por: Schapiro, J
Publicado: (2010)

Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure
por: Fernández-Caballero, Jose Ángel, et al.
Publicado: (2016)

Definition and reporting of pilot and feasibility studies
por: Eldridge, Sandra, et al.
Publicado: (2013)

Using discrete choice experiments to define patient preferences for outcomes in trials
por: Fargher, Emily, et al.
Publicado: (2013)

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
por: Wheatley, AK, et al.
Publicado: (2009)

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
por: Pillay, D, et al.
Publicado: (2010)

Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort
por: Obermeier, MJ, et al.
Publicado: (2010)

Naturally occurring protease inhibitor resistance mutations and their frequencies in HIV proviral sequences of drug-naïve sex workers in Nairobi, Kenya
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qnec6omofv07cqaa87m6v8lh6o